The Global Cannabis Market Is Set To Explode / Commodities / Cannabis

As the global marijuana industry booms,one little company has just hit a huge payday.

Scythian Biosciences Corp. (TSXV:SCYB.V; OTC:SCCYF) isa tiny company with a big secret: a way to turn cannabis assets across theworld into investments worth hundreds of millions.

Thecompany is making a transition from biosciences to investment, and it’s juststruck it rich.

Scythian has accomplished a huge coupe: it’s agreedto sell its assets in Jamaica and LatinAmerica to Aphria, the marijuana giant, for$193 million.

 That’s because weed is GLOBAL. It’s much, muchmore than Canada and the US.

The global weed sector could beworth $57 billion in justyears, and that is mainly focused on the recreational market.

But there are better ways toprofit from the Green Revolution…ways that the hedge funds and venturecapitalists haven’t discovered yet.

Scythian knows the secrets tomaking minor marijuana assets into a $193 millioninvestment.

It’s the only truly global cannabis opportunity spotter,an incubator for marijuana ventures and research throughout the world.

Everyone’s been payingattention to the North American weed market…but they’ve been missing the bigpicture.

1.37 billion people in Europe and LatinAmerica could soon gain access to legal marijuana. And most people have noidea.

But the team at Scythian Biosciences Corp. (TSXV: SCYB.V; OTC:SCCYF) sure does.

They’ve got a presence in someof the key markets there, and now they’re targeting acquiringnew investments in Brazil.

Scythian’s got millionsof dollars in seed money from Aphria Inc. (OTCMKTS: APHQF), a $2.952billion behemoth and one of the biggest sharks in the cannabis sector.

And whatthey’ve done is ingenuous: acquiring and incubating assets with cash fromAphria, only to sell them back for a huge payday.

Scythian is going to make $193 million from its saleof assets to Aphria… and plans are for this to be just the beginning.

 They’re getting ready to duplicate this type of deal over and over, aiming forhigh profits.

# 1 Tipping Point for an expected $57Billion Market…

Cannabis has been one of thebiggest stories of 2018…but few have grasped the size of the opportunity.

The move from illegal to legalis happening at a rapid pace.

A report fromArcview Market Research and BDS Analytics found cannabis sales accounted for$9.5 billion in consumer spending.

The total size of the globalcannabis market is estimated to reach $32 billion by 2022 and $57billion by 2027.

The bulk of pot sales are inthe United States, which at the moment has a patchwork of state regulationsdictating how marijuana can be sold and consumed legally.

But North American potconsumption is bound to rise rapidly, led by groundbreaking Canadianlegalization this year.

Canadians spent $5.7billion on cannabis products in 2017, but withrecreational pot now about tobe legal, that figure could explode asmillions of new users start lighting up legally.

Across North America, marijuanais having itsbest year ever. Support for legalizing weed across theU.S. is at its highest level in years—polls find as much as 80percent in favor.

And the limited space formedical marijuana is blossoming into a much broader market, one that includesrecreational marijuana use and marijuana-based pharmaceutical products.

The FDA, for instance, justapproved the firstever drug based on cannabis.

States are rushing towardslegalization: super-conservativeOklahoma, for instance, just legalized medicalmarijuana, becoming the 30th state to do so.

States like Oklahoma aredesperate for tax revenue…the kind that a new green pot industry could bringgenerate.

States like Vermont, Michiganand California are lining up to expand pot and make a killing.

With such momentum, $57 billion by 2027 may be a conservative estimate. The greener North Americagets, the bigger the opportunity in pot becomes.

# 2 …And That’s Just the Beginning

North America is driving aninvestment surge in the cannabis sector.

But the opportunity is evenbigger than people have realized.

Scythian Biosciences Corp. (TSXV: SCYB.V; OTC:SCCYF) is unique because it taps intothis opportunity…something that firms focused on North America have overlooked.

The company got its start inbiosciences, but now it’s made the transition to investing and incubatingmarijuana assets.

Scythian’s approach is toidentify quality assets and build them up into something of value—an approachit clearly demonstrated with its recently announced asset sale to Aphria.

It’s the “first mover”approach—search out corners of the market for the assets no one else has found.Scythian sets up strategic “cultivation hubs” with local partners, and alsoworks with medical institutions

Scythian’s model gains exposure to thewhole global cannabis market and accesses assets that, when they meet their goals, can go from pennies to millions in just a few short months.

One such avenue for exposure isin Latin America, where Scythian has already laid down a foundation.

And the European market couldbe even bigger. The continent has twice as many people as the U.S. and couldprovide doublethe sales, once laws are relaxed.

Scythian has a plan inplace to tap into the European market, laying a foundation in a number of keymarkets including Italy and the United Kingdom.

The UK, where newcannabis laws could be justaround the corner, could be a huge opportunity—a country whereblack market marijuana salestotaled $3.46 billion and counted 3 million users.

When European laws change, Scythian should be in prime position to seize a chunk of the market.

# 3 Diversification

Scythian’s (TSXV:SCYB.V; OTC:SCCYF) plan is bigger than justproduction and distribution. The company invests in every part of the cannabissupply chain.

It is also setting out toincubate marijuana distributors across the world—building markets that bothAphria and Scythian can exploit with Canadian pot.

There are lots of differentopportunities for Scythian to hit it big. A consumer marijuana product, a “CocaCola” for pot smokers, could let it tap into the recreational market.

A “Pfizer,” on the other hand,would let it access the medical marijuana industry, one that could grow byleaps and bounds if more marijuana-baseddrugs receive approval from the FDA.

Scythian could be bringing in ahuge payday: announcing anagreement to sell off its Colombian,Argentinian and Jamaican assets to Aphria for $193million.

Beyond distribution, Scythianis incubating marijuana research ventures at the University of Miami,University College Dublin, Universidad de la Plata and the University of WestIndies.

From these investments, Scythiancould acquire lucrative new patents for marijuana products—from cannabis oilsto new strains of pot to pill-based THC consumables.

Scythian could be granted profitablepatents, then watch the money roll in from licensing.

# 4 Global Firm, Global Vision

The team at Scythian (TSXV:SCYB.V; OTC:SCCYF) is dedicated, professional—andled by a true visionary.

GeorgeScorsis sits on the Board of Directors for Scythian.Over fifteen years, Scorsis has led a number of companies to rapid growth, allin highly regulated fields from alcohol to energy drinks (he was key indeveloping RedBull, the super popular energy drink) to medical cannabis.

Formerly serving as Presidentof Mettrum Health Corp, Scorsis built that company into a $340 million concern,just before selling it to the Canadian marijuana giant Canopy Growth Corp.

The management team behind Scythianis a huge, 75-person squad scattered across the globe in Scythian’s differentregional offices: Europe, Latin America, the Caribbean and North America.

These pros are identifying andincubating marijuana ventures in a dozen different time zones.

Scythian has access to allthese opportunities and the company has harnessed the brain-power to tap into them.

#5 Global Cannabis Market

Scythian (TSXV:SCYB.V; OTC:SCCYF) has been lurking in theshadows, but now it’s about to burst on to the scene.

And Aprhia is one of thebiggest players in the marijuana space: a $2.952 billion company that dominatesmedical marijuana and is boundto profit from Canada’s legalization.

The cannabis market may haveattracted some big money, but NOBODY has realized the potential of the globalweed market…except for Scythian.

And with Aphria backing them, thislittle company is planning to make some big moves in Italy, Portugal and the UK.They’re basically incubating market outlets for Aphria’s product.

ather than banking on fly-by-wire growers inNorth America, where markets might get saturated with pot, savvy companies should look abroad, where billions of customers remainunderserved and where legalization legislation is probably not faroff.

As many 1.37 billion peoplein Europe and Latin America may soon be free to shop for pot.

And Scythian wants to bring itto them before the competition discovers the opportunities.

By. Ian Jenkins

**IMPORTANT! BY READING OURCONTENT YOU EXPLICITLY AGREE TO THE FOLLOWING. PLEASE READ CAREFULLY**

Notice for Forward-LookingInformation
Certainstatements in this press release are forward-looking statements and areprospective in nature. Forward-looking statements are not based on historicalfacts, but rather on current expectations and projections about future events,and are therefore subject to risks and uncertainties which could cause actualresults to differ materially from the future results expressed or implied bythe forward-looking statements. Such forward-looking information includesinformation relating to Scythian’s proposed acquisition of Marigold, MMJColombia, ABP and ColCanna; the expected sale of these  companies to Aphria and resulting receipt of$193M from Aphria; that cannabis use and sales will grow as predicted;Scythian’s intended acquisition of a Brazil company and potential sale toAphria; that Scythian will be in a prime position in the UK and Europe to takea substantial portion of the cannabis market when laws permit; its plans toincubate projects in various locations throughout the world; it could begranted licensable patents; and that it’s traumatic brain injury solutions willbe accepted by medical practitioners.

Readersare cautioned to not place undue reliance on forward-looking information.Forward looking information is subject to a number of risks and uncertaintiesthat may cause actual results or events to differ materially from thosecontemplated in the forward-looking information, and even if such actualresults or events are realized or substantially realized, there can be noassurance that they will have the expected consequences to, or effects on theCompany. Such risks and uncertainties include, among other things: that aregulatory approval that may be required for the intended acquisitions andsubsequent sale are not obtained or are obtained subject to conditions that arenot anticipated; that a condition to the completion of the intendedacquisitions or sale may not be satisfied; construction delays and costsoverruns; potential future competition in the markets Scythian operates; thatScythian’s technology may not achieve the expected results and itsaccomplishments may be limited; that Scythian may not establish a market forits services as expected; competitors may quickly enter the industry; generaleconomic conditions in the US, Canada and globally; the inability to securefinancing necessary to carry out its business plans; competition for, amongother things, capital and skilled personnel; the possibility that governmentpolicies or laws may change; technological change may result in Scythian’ssolutions not be the best or cheapest available; Scythian not adequatelyprotecting its intellectual property; interruption or failure of informationtechnology systems; the cannabis market may not grow as expected; Scythian’stechnology may not achieve the expected results and its accomplishments may belimited; even if it is granted patents, it may not have success at licensingits technologies; Scythian’s business plan also carries risk, including itsability to comply with all applicable governmental regulations in a highlyregulated business; investing in target companies or projects which havelimited or no operating history and are engaged in activities currentlyconsidered illegal under US federal laws; changes in laws; and regulatory risksrelating to Scythian’s business, financings and strategic acquisitions.

DISCLAIMERS

PAID ADVERTISEMENT. This communication is a paid advertisement and is not a recommendation to buyor sell securities. Oilprice.com, Advanced Media Solutions Ltd, and theirowners, managers, employees, and assigns (collectively “the Company”) has beenpaid by the profiled company or a third party to disseminate thiscommunication. In this case the Company has been paid by Scythian Fifty-eightthousand three hundred thirty three US dollars for this landing page andcertain banner ads. This compensation is a major conflict with our ability tobe unbiased, more specifically:

This communication is for entertainment purposes only. Never invest purelybased on our communication. Gains mentioned in our newsletter and on ourwebsite may be based on end-of- day or intraday data. We have been compensatedby Scythian to conduct investor awareness advertising and marketing forScythian. Therefore, this communication should be viewed as a commercialadvertisement only. We have not investigated the background of the company. Thethird party, profiled company, or their affiliates may liquidate shares of theprofiled company at or near the time you receive this communication, which hasthe potential to hurt share prices. Frequently companies profiled in our alertsexperience a large increase in volume and share price during the course ofinvestor awareness marketing, which often end as soon as the investor awarenessmarketing ceases. The investor awareness marketing may be as brief as one day,after which a large decrease in volume and share price is likely to occur.

We do not guarantee the timeliness, accuracy, or completeness of theinformation on our site or in our newsletters. The information in ourcommunications and on our website is believed to be accurate and correct, buthas not been independently verified and is not guaranteed to be correct. Theinformation is collected from public and non-public sources but is notresearched or verified in any way whatsoever to ensure the information iscorrect.

SHARE OWNERSHIP. The owner of Oilprice.comowns shares and/or stock options of this featured company and therefore has anadditional incentive to see the featured company’s stock perform well. Theowner of Oilprice.com will not notify the market when it decides to buy or sellshares of this issuer in the market. The owner of Oilprice.com will be buyingand selling shares of the featured company for its own profit. This is why westress that you conduct extensive due diligence as well as seek the advice ofyour financial advisor or a registered broker-dealer before investing in anysecurities.

NOT AN INVESTMENT ADVISOR. TheCompany is not registered or licensed by any governing body in any jurisdictionto give investing advice or provide investment recommendation. ALWAYS DO YOUROWN RESEARCH and consult with a licensed investment professional before makingan investment. This communication should not be used as a basis for making anyinvestment.

INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer,including, but not limited to: releasing The Company, its affiliates, assignsand successors from any and all liability, damages, and injury from theinformation contained in this communication. You further warrant that you aresolely responsible for any financial outcome that may come from your investmentdecisions.

RISK OF INVESTING. Investing isinherently risky. While a potential for rewards exists, by investing, you areputting yourself at risk. You must be aware of the risks and be willing toaccept them in order to invest in any type of security. Don't trade with moneyyou can't afford to lose. This is neither a solicitation nor an offer toBuy/Sell securities.

TERMS OF USE. By reading thiscommunication you agree that you have reviewed and fully agree to the Terms ofUse found here http://oilprice.com/terms-and-conditions If you do not agree tothe Terms of Use http://oilprice.com/terms-and-conditions, please contactOilprice.com to discontinue receiving future communications.

© 2005-2018 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.